Literature DB >> 375850

Naproxen in juvenile chronic polyarthritis.

H Moran, D B Hanna, B M Ansell, M Hall, C Engler.   

Abstract

Naproxen at 10 mg per kg body weight was compared with aspirin at 80 mg per kg body weight in children suffering from juvenile chronic polyarthritis. It was found to be as effective as aspirin, with certainly no more and possibly fewer gastrointestinal side effects. A long-term tolerance study up to 12 months confirmed that naproxed was a satisfactory nonsteroidal anti-inflammatory drug in the management of various types of juvenile chronic arthritis.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 375850      PMCID: PMC1000341          DOI: 10.1136/ard.38.2.152

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  4 in total

1.  Naproxen absorption in children.

Authors:  B M Ansell; D B Hanna; M Stoppard
Journal:  Curr Med Res Opin       Date:  1975       Impact factor: 2.580

2.  Prognosis in Still's disease.

Authors:  B M ANSELL; E G BYWATERS
Journal:  Bull Rheum Dis       Date:  1959-05

3.  Naproxen. A new non-hormonal anti-inflammatory agent. Studies in rheumatoid arthritis.

Authors:  H F Hill; A G Hill; A G Mowat; B M Ansell; J A Mathews; M H Seifert; J M Gumpel; G A Christie
Journal:  Ann Rheum Dis       Date:  1974-01       Impact factor: 19.103

4.  Ibuprofen in the management of Still's disease.

Authors:  B M Ansell
Journal:  Practitioner       Date:  1973-11
  4 in total
  8 in total

Review 1.  Medical management of children with juvenile rheumatoid arthritis.

Authors:  J T Cassidy
Journal:  Drugs       Date:  1999-11       Impact factor: 9.546

Review 2.  Assessment and management of pain in juvenile idiopathic arthritis.

Authors:  Jennifer E Weiss; Nadia J C Luca; Alexis Boneparth; Jennifer Stinson
Journal:  Paediatr Drugs       Date:  2014-12       Impact factor: 3.022

Review 3.  2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: initiation and safety monitoring of therapeutic agents for the treatment of arthritis and systemic features.

Authors:  Timothy Beukelman; Nivedita M Patkar; Kenneth G Saag; Sue Tolleson-Rinehart; Randy Q Cron; Esi Morgan DeWitt; Norman T Ilowite; Yukiko Kimura; Ronald M Laxer; Daniel J Lovell; Alberto Martini; C Egla Rabinovich; Nicolino Ruperto
Journal:  Arthritis Care Res (Hoboken)       Date:  2011-04       Impact factor: 4.794

4.  Outpatient Pain Management in Children With Chronic Pancreatitis: A Scoping Systematic Review.

Authors:  Emily R Perito; John F Pohl; Caitlin Bakker; Matthew A Armfield; Bradley Barth; Addison Cuneo; Maria Mascarenhas; Megha Mehta; Sarah Jane Schwarzenberg
Journal:  Pancreas       Date:  2022-02-01       Impact factor: 3.327

Review 5.  Efficacy and Safety of NSAIDs in Infants: A Comprehensive Review of the Literature of the Past 20 Years.

Authors:  Victoria C Ziesenitz; Tatjana Welzel; Madelé van Dyk; Patrick Saur; Matthias Gorenflo; Johannes N van den Anker
Journal:  Paediatr Drugs       Date:  2022-09-02       Impact factor: 3.930

Review 6.  Sumatriptan-naproxen fixed combination for acute treatment of migraine: a critical appraisal.

Authors:  Chaouki K Khoury; James R Couch
Journal:  Drug Des Devel Ther       Date:  2010-02-18       Impact factor: 4.162

Review 7.  Clinical pharmacokinetics of drugs used in juvenile arthritis.

Authors:  K J Skeith; F Jamali
Journal:  Clin Pharmacokinet       Date:  1991-08       Impact factor: 6.447

Review 8.  Naproxen up to date: a review of its pharmacological properties and therapeutic efficacy and use in rheumatic diseases and pain states.

Authors:  R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1979-10       Impact factor: 9.546

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.